Cargando…

Gene expression profiling of cutaneous wound healing

BACKGROUND: Although the sequence of events leading to wound repair has been described at the cellular and, to a limited extent, at the protein level this process has yet to be fully elucidated. Genome wide transcriptional analysis tools promise to further define the global picture of this complex p...

Descripción completa

Detalles Bibliográficos
Autores principales: Deonarine, Kavita, Panelli, Monica C, Stashower, Mitchell E, Jin, Ping, Smith, Kina, Slade, Herbert B, Norwood, Christopher, Wang, Ena, Marincola, Francesco M, Stroncek, David F
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1804259/
https://www.ncbi.nlm.nih.gov/pubmed/17313672
http://dx.doi.org/10.1186/1479-5876-5-11
_version_ 1782132443025768448
author Deonarine, Kavita
Panelli, Monica C
Stashower, Mitchell E
Jin, Ping
Smith, Kina
Slade, Herbert B
Norwood, Christopher
Wang, Ena
Marincola, Francesco M
Stroncek, David F
author_facet Deonarine, Kavita
Panelli, Monica C
Stashower, Mitchell E
Jin, Ping
Smith, Kina
Slade, Herbert B
Norwood, Christopher
Wang, Ena
Marincola, Francesco M
Stroncek, David F
author_sort Deonarine, Kavita
collection PubMed
description BACKGROUND: Although the sequence of events leading to wound repair has been described at the cellular and, to a limited extent, at the protein level this process has yet to be fully elucidated. Genome wide transcriptional analysis tools promise to further define the global picture of this complex progression of events. STUDY DESIGN: This study was part of a placebo-controlled double-blind clinical trial in which basal cell carcinomas were treated topically with an immunomodifier – toll-like receptor 7 agonist: imiquimod. The fourteen patients with basal cell carcinoma in the placebo arm of the trial received placebo treatment consisting solely of vehicle cream. A skin punch biopsy was obtained immediately before treatment and at the end of the placebo treatment (after 2, 4 or 8 days). 17.5K cDNA microarrays were utilized to profile the biopsy material. RESULTS: Four gene signatures whose expression changed relative to baseline (before wound induction by the pre-treatment biopsy) were identified. The largest group was comprised predominantly of inflammatory genes whose expression was increased throughout the study. Two additional signatures were observed which included preferentially pro-inflammatory genes in the early post-treatment biopsies (2 days after pre-treatment biopsies) and repair and angiogenesis genes in the later (4 to 8 days) biopsies. The fourth and smallest set of genes was down-regulated throughout the study. Early in wound healing the expression of markers of both M1 and M2 macrophages were increased, but later M2 markers predominated. CONCLUSION: The initial response to a cutaneous wound induces powerful transcriptional activation of pro-inflammatory stimuli which may alert the host defense. Subsequently and in the absence of infection, inflammation subsides and it is replaced by angiogenesis and remodeling. Understanding this transition which may be driven by a change from a mixed macrophage population to predominately M2 macrophages, may help the interpretation of the cellular and molecular events occurring in the microenvironment of serially biopsied tissues.
format Text
id pubmed-1804259
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18042592007-02-24 Gene expression profiling of cutaneous wound healing Deonarine, Kavita Panelli, Monica C Stashower, Mitchell E Jin, Ping Smith, Kina Slade, Herbert B Norwood, Christopher Wang, Ena Marincola, Francesco M Stroncek, David F J Transl Med Research BACKGROUND: Although the sequence of events leading to wound repair has been described at the cellular and, to a limited extent, at the protein level this process has yet to be fully elucidated. Genome wide transcriptional analysis tools promise to further define the global picture of this complex progression of events. STUDY DESIGN: This study was part of a placebo-controlled double-blind clinical trial in which basal cell carcinomas were treated topically with an immunomodifier – toll-like receptor 7 agonist: imiquimod. The fourteen patients with basal cell carcinoma in the placebo arm of the trial received placebo treatment consisting solely of vehicle cream. A skin punch biopsy was obtained immediately before treatment and at the end of the placebo treatment (after 2, 4 or 8 days). 17.5K cDNA microarrays were utilized to profile the biopsy material. RESULTS: Four gene signatures whose expression changed relative to baseline (before wound induction by the pre-treatment biopsy) were identified. The largest group was comprised predominantly of inflammatory genes whose expression was increased throughout the study. Two additional signatures were observed which included preferentially pro-inflammatory genes in the early post-treatment biopsies (2 days after pre-treatment biopsies) and repair and angiogenesis genes in the later (4 to 8 days) biopsies. The fourth and smallest set of genes was down-regulated throughout the study. Early in wound healing the expression of markers of both M1 and M2 macrophages were increased, but later M2 markers predominated. CONCLUSION: The initial response to a cutaneous wound induces powerful transcriptional activation of pro-inflammatory stimuli which may alert the host defense. Subsequently and in the absence of infection, inflammation subsides and it is replaced by angiogenesis and remodeling. Understanding this transition which may be driven by a change from a mixed macrophage population to predominately M2 macrophages, may help the interpretation of the cellular and molecular events occurring in the microenvironment of serially biopsied tissues. BioMed Central 2007-02-21 /pmc/articles/PMC1804259/ /pubmed/17313672 http://dx.doi.org/10.1186/1479-5876-5-11 Text en Copyright © 2007 Deonarine et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Deonarine, Kavita
Panelli, Monica C
Stashower, Mitchell E
Jin, Ping
Smith, Kina
Slade, Herbert B
Norwood, Christopher
Wang, Ena
Marincola, Francesco M
Stroncek, David F
Gene expression profiling of cutaneous wound healing
title Gene expression profiling of cutaneous wound healing
title_full Gene expression profiling of cutaneous wound healing
title_fullStr Gene expression profiling of cutaneous wound healing
title_full_unstemmed Gene expression profiling of cutaneous wound healing
title_short Gene expression profiling of cutaneous wound healing
title_sort gene expression profiling of cutaneous wound healing
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1804259/
https://www.ncbi.nlm.nih.gov/pubmed/17313672
http://dx.doi.org/10.1186/1479-5876-5-11
work_keys_str_mv AT deonarinekavita geneexpressionprofilingofcutaneouswoundhealing
AT panellimonicac geneexpressionprofilingofcutaneouswoundhealing
AT stashowermitchelle geneexpressionprofilingofcutaneouswoundhealing
AT jinping geneexpressionprofilingofcutaneouswoundhealing
AT smithkina geneexpressionprofilingofcutaneouswoundhealing
AT sladeherbertb geneexpressionprofilingofcutaneouswoundhealing
AT norwoodchristopher geneexpressionprofilingofcutaneouswoundhealing
AT wangena geneexpressionprofilingofcutaneouswoundhealing
AT marincolafrancescom geneexpressionprofilingofcutaneouswoundhealing
AT stroncekdavidf geneexpressionprofilingofcutaneouswoundhealing